Journal
REPRODUCTION
Volume 126, Issue 5, Pages 559-567Publisher
BIOSCIENTIFICA LTD
DOI: 10.1530/rep.0.1260559
Keywords
-
Categories
Funding
- MRC [MC_U127684438] Funding Source: UKRI
- Medical Research Council [U.1276.00.004.00002.01/2(61014), MC_U127684438] Funding Source: Medline
Ask authors/readers for more resources
Prostaglandins are bioactive lipids produced from arachidonic acid by cyclooxygenase (COX) enzymes and specific terminal prostanoid synthase enzymes. After biosynthesis, prostaglandins exert an autocrine-paracrine function by coupling to specific prostanoid G protein-coupled receptors to activate intracellular signalling and gene transcription. For many years, prostaglandins have been recognized as key molecules in reproductive biology by regulating ovulation, endometrial physiology and proliferation of endometrial glands and menstruation. More recently, a role for COX enzymes and prostaglandins has been ascertained in reproductive tract pathology, including carcinomas, menorrhagia, dysmenorrhoea and endometriosis. Although the mechanism by which prostaglandins modulate these pathologies is still unclear, a large body of evidence supports a role for COX enzymes, prostaglandins and prostaglandin receptor signalling pathways in angiogenesis, apoptosis and proliferation, tissue invasion and metastases and immunosuppression. Here, an overview is provided of some of the findings from these studies with specific emphasis on the role of COX enzymes, prostaglandin E-2 and F-2alpha in disorders of endometrial proliferation and menstruation in non-pregnant women.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available